Population pharmacokinetic study of delayed methotrexate excretion in children with acute lymphoblastic leukemia .
CONCLUSION: The final model was demonstrated as appropriate and effective for assessing the pharmacokinetic parameters of delayed MTX excretion in children with ALL.
.
PMID: 31232278 [PubMed - as supplied by publisher]
Source: International Journal of Clinical Pharmacology and Therapeutics - Category: Drugs & Pharmacology Tags: Int J Clin Pharmacol Ther Source Type: research
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Bilirubin | Children | Drugs & Pharmacology | Leukemia | Methotrexate | Study